Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing CR Double-Crane Shenlu Pharmaceutical Co., Ltd. is a key pharmaceutical manufacturing subsidiary of China Resources Double-Crane Pharmaceutical, based in Beijing, China. The company specializes in the development and production of oral solid dosage forms, with a strong focus on chronic disease management and pediatric medicine. Its extensive product portfolio includes treatments for hypertension, diabetes, and cardiovascular conditions, often marketed under the well-established 'Shenlu' brand. As part of the larger China Resources Group, the company operates high-capacity, GMP-certified production facilities that supply essential medicines to the domestic Chinese market. Shenlu Shuanghe is recognized for integrating modern pharmaceutical chemical processing with a legacy of reliable healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CR Double-Crane Shenlu Pharmaceutical.